1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cardiometabolic Drug News MARCH 2015

Cardiometabolic Drug News MARCH 2015

  • March 2015
  • -
  • Espicom Business Intelligence
  • -
  • 15 pages

Industry Trend Analysis - Sanofi's Lantus Successor Will See EC Approval And US Launch In Q215
Industry Brief - Amarin/Eddingpharm Enter Agreement For Vascepa In China
Industry Brief - Islet/BHV Enter Exclusive Licence Agreement For Phase II SGLT2 Inhibitor
Industry Brief - Laguna Completes Series B Financing; Appoints CEO
Industry Brief - Dance Biopharm Completes Private Financing
Industry Brief - Armetheon Raises Funds To Advance Tecarfarin Development In US
Industry Brief - AstraZeneca Gains Planning Consent For Global R&D Centre/Corporate HQ In Cambridge
Industry Brief - Savaysa Available In US Pharmacies
Industry Brief - Novartis' LCZ696 Gains FDA Priority Review For HFrEF
Industry Brief - Sandoz Launches Telmisartan In US
Industry Brief - Health Canada Approves Saxenda For Chronic Weight Management
Industry Brief - Glenmark Launches Trandolapril+Verapamil In US
Industry Brief - Actelion's NDA For Uptravi Accepted By FDA With Standard Review Time
Industry Brief - Eisai Meets Paediatric Needs With Tambocor Fine Granule Formulation
Industry Brief - Bayer's Adempas Approved In Japan For PAH
Industry Brief - BI Submits Idarucizumab BLA As Specific Reversal Agent For Pradaxa
Industry Brief - BI Submits Idarucizumab Applications In US/EU/Canada
Industry Trend Analysis - Controversial Data Suggest Advantage For Contrave In Obesity Market
Industry Trend Analysis - J&J Guiding Drug Development With New Research Platforms
Industry Brief - Lilly Accepts Recommendation To Extend Evacetrapib Phase III Trial
Industry Brief - Novo Nordisk Reports Positive Phase II Results With Oral Semaglutide For Type II Diabetes
Industry Brief - Lilly Delays Regulatory Submission Of Basal Insulin Peglispro
Industry Brief - Mast Initiates Phase IIa Studies Of AIR001 In HFpEF
Industry Brief - Melior Initiates Phase II Study With MLR-1023 For Type II Diabetes
Industry Brief - ARCA Granted US Patent Covering Gencaro
Industry Brief - La Jolla/FDA Reach SPA Agreement On LJPC-501 Phase III Trial In CRH
Industry Brief - MBT Receives US Patent NoA Covering Glyceollin For Diabetes/Obesity
Industry Brief - Positive Results From Adocia's HinsBet Fast Acting Insulin Formulation In Phase IIa Trial

Table Of Contents

Cardiometabolic Drug News MARCH 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.